Take Two Iron Chelators and Call Me in the Morning
Volume: 1, Issue: 3, Pages: 2a - 2a
Published: Oct 1, 2012
Abstract
In a report by Hadziahmetovic et al,1 oral administration of an iron chelator deferiprone (Ferriprox), which was recently approved by the Food and Drug Administration, showed substantial protection against retinal degeneration both in a chemically induced (NaIO3) mouse model as well as in a rd6 mouse, which exhibits a hereditary, slowly progressing retinal degeneration that mainly affects the RPE and photoreceptor cells. These authors previously...
Paper Details
Title
Take Two Iron Chelators and Call Me in the Morning
Published Date
Oct 1, 2012
Volume
1
Issue
3
Pages
2a - 2a
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History